IR8

From WikiMD's Medical Encyclopedia

IR8 is a high-yielding variety of rice that was developed in the 1960s by the International Rice Research Institute (IRRI). It is often referred to as "miracle rice" due to its ability to prevent famine in several Asian countries.

History[edit]

IR8 was developed by crossbreeding two varieties of rice, one from Indonesia and one from China. The goal was to create a strain that could withstand a variety of growing conditions and produce a high yield. The result was a variety that could produce up to ten times the yield of traditional rice varieties.

The development of IR8 marked the beginning of the Green Revolution, a period of significant increase in agricultural production due to the use of new technologies and methods. The success of IR8 led to the development of other high-yield varieties, which have played a crucial role in preventing famine in many parts of the world.

Characteristics[edit]

IR8 is a semi-dwarf variety, which makes it resistant to lodging, a common problem in rice cultivation where plants fall over due to wind or rain. It also has a short growing period, allowing farmers to grow more than one crop per year.

Despite its high yield, IR8 has fallen out of favor in recent years due to its taste. Many consumers prefer the taste of traditional varieties, leading to a decrease in the cultivation of IR8.

Impact[edit]

The introduction of IR8 has had a significant impact on global food security. It has been estimated that the use of IR8 and other high-yield varieties has saved millions of lives by preventing famine.

However, the reliance on a small number of high-yield varieties has also led to a decrease in biodiversity, which could have long-term implications for food security. There are also concerns about the environmental impact of the intensive farming methods associated with high-yield varieties.

See also[edit]



Stub icon
   This article is a agriculture stub. You can help WikiMD by expanding it!



This article is a stub related to food. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes


Ad. Transform your life with W8MD's

GLP-1 weight loss injections special from $29.99

W8MD weight loss doctors team
W8MD weight loss doctors team

W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss

Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots

Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:

✔ Most insurances accepted for visits ✔ Prior authorization support when eligible

Start your physician weight loss NYC journey today:

📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center

📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)

Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss


Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.